Safety for vaccine(e)s.
作者信息
Merten O W
机构信息
Généthon III; 1, Rue de l'Internationale, F-91002, Evry-Cedex, France.
出版信息
Cytotechnology. 2000 Nov;34(3):181-3. doi: 10.1023/A:1008160817560.
Abstract
摘要
相似文献
1
Safety for vaccine(e)s.疫苗的安全性。
Cytotechnology. 2000 Nov;34(3):181-3. doi: 10.1023/A:1008160817560.
2
Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.RTS,S/AS01E 疟疾疫苗候选者在 5 至 17 个月大的肯尼亚和坦桑尼亚儿童中的安全性。
PLoS One. 2010 Nov 29;5(11):e14090. doi: 10.1371/journal.pone.0014090.
3
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.RTS,S/AS01E 候选疟疾疫苗与扩大免疫规划疫苗联合接种的安全性和有效性：一项随机、开放标签、2 期临床试验的 19 个月随访。
Lancet Infect Dis. 2011 Oct;11(10):741-9. doi: 10.1016/S1473-3099(11)70100-1. Epub 2011 Jul 22.
4
Impact of social media news on COVID-19 vaccine hesitancy and vaccination behavior.社交媒体新闻对新冠疫苗犹豫及接种行为的影响
Telemat Inform. 2023 May;80:101983. doi: 10.1016/j.tele.2023.101983. Epub 2023 Apr 23.
5
Assessing the safety, impact and effectiveness of RTS,S/AS01 malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up.在 RTS,S/AS01 疟疾疫苗在三个撒哈拉以南非洲国家引入后，评估其安全性、影响和效果：方法学方法和研究设计。
Malar J. 2022 Apr 25;21(1):132. doi: 10.1186/s12936-022-04144-3.
6
Overview of U.S. COVID-19 vaccine safety surveillance systems.美国 COVID-19 疫苗安全监测系统概述。
Vaccine. 2024 Sep 17;42 Suppl 3:125748. doi: 10.1016/j.vaccine.2024.02.065. Epub 2024 Apr 16.
7
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial.莫桑比克儿童在IIb期试验中使用RTS,S/AS02A疟疾疫苗的安全性。
Vaccine. 2008 Jan 10;26(2):174-84. doi: 10.1016/j.vaccine.2007.11.003. Epub 2007 Nov 26.
8
Formal training in vaccine safety to address parental concerns not routinely conducted in U.S. pediatric residency programs.美国儿科住院医师培训项目通常不提供针对解决家长担忧的疫苗安全性正规培训。
Vaccine. 2014 May 30;32(26):3175-8. doi: 10.1016/j.vaccine.2014.04.001. Epub 2014 Apr 13.
9
Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.新型稳定剂/缓冲液配方的G1和G2人重配轮状病毒疫苗在健康婴儿中的安全性、免疫原性和有效性。
Pediatr Infect Dis J. 2003 Oct;22(10):914-20. doi: 10.1097/01.inf.0000091887.48999.77.
10
Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.复制缺陷型人腺病毒载体口蹄疫病毒 A24 亚型亚单位疫苗在牛中的安全性。
Transbound Emerg Dis. 2018 Apr;65(2):447-455. doi: 10.1111/tbed.12724. Epub 2017 Oct 27.
引用本文的文献
1
Real-time monitoring of adherent Vero cell density and apoptosis in bioreactor processes.生物反应器过程中贴壁Vero细胞密度和凋亡的实时监测。
Cytotechnology. 2012 Aug;64(4):429-41. doi: 10.1007/s10616-011-9421-2. Epub 2012 Feb 25.
2
Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium.无血清培养基中 MDCK 细胞生产流感 H5N1 灭活疫苗。
PLoS One. 2011 Jan 24;6(1):e14578. doi: 10.1371/journal.pone.0014578.
本文引用的文献
1
Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors.评价无血清培养基 MDSS2 在生物反应器中生产脊髓灰质炎病毒在vero 细胞上的应用。
Cytotechnology. 1997 Nov;25(1-3):35-44. doi: 10.1023/A:1007999313566.
2
The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses.新型无动物蛋白培养基 MDSS2N 支持细胞生长和各种病毒的生产。
Cytotechnology. 1999 Jul;30(1-3):191-201. doi: 10.1023/A:1008021317639.
3
Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.流感疫苗：一种基于马-达二氏犬肾（MDCK）细胞培养的安全流感疫苗。
Dev Biol Stand. 1999;98:93-100; discussion 111.
4
An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.一种采用新型BHK - 21悬浮细胞培养工艺生产的实验性狂犬病疫苗：无血清培养基和灌注反应器系统的应用。
Vaccine. 1995 Sep;13(13):1244-50. doi: 10.1016/0264-410x(94)00022-f.
5
Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus.β-丙内酯处理会损害感染狂犬病病毒的BHK-21细胞残留DNA的生物活性。
Vaccine. 1993;11(1):82-90. doi: 10.1016/0264-410x(93)90343-v.
6
Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses.Vero细胞的无蛋白培养：人类致病病毒复制的一种底物
Cell Biol Int. 1993 Sep;17(9):885-95. doi: 10.1006/cbir.1993.1152.
7
Ongoing tragedy of rabies.狂犬病的持续悲剧。
Lancet. 1993 Oct 30;342(8879):1067-8. doi: 10.1016/0140-6736(93)92058-2.
8
[Current situation on human rabies control and anti-rabies vaccination].
Sante. 1994 May-Jun;4(3):203-4.
9
Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.新型无血清培养基（MDSS2）用于生产不同生物制品的评估：多种细胞系的应用。
Cytotechnology. 1994;14(1):47-59. doi: 10.1007/BF00772195.
10
Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier.通过在微载体上培养Vero细胞制备灭活脊髓灰质炎病毒疫苗的工业化规模生产。
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S341-4. doi: 10.1093/clinids/6.supplement_2.s341.
Zotero 插件